The global infection prevention product and services market is estimated to increase at a CAGR of 5.86%, from a market size of US$123.150 billion in 2020 to a market size of US$183.530 billion by the end of 2027.
The growing number of acute and chronic diseases is further propelling the market growth in the forecast period. Chronic diseases include cardiovascular diseases, the prevalence of cancer, asthma, and COPD, among others. Concerns regarding hospital-associated infections, surgical-site infections, and medical waste disposal are providing an opportunity for the market to proliferate in the forecast period and the coming years.
On the basis of Geography, North America is estimated to hold a significant market share with the presence of advanced health facilities. Hence, efforts are made to maintain these facilities with an emphasis on infection prevention and control. Additionally, the presence of prominent market players in the region is further burgeoning the market demand in the forecast period and the coming years. On the other hand, the Asia Pacific region is the fastest-growing due to the high prevalence of chronic diseases demanding treatments. Also, with the highest number of geriatric populations in Japan, the APAC region holds strong growth prospects for the market to grow significantly in the forecast period.
Furthermore, the booming medical tourism industry and the growing number of surgeries, along with minimally invasive and robotic surgeries, are further propelling the market demand in the forecast period.
Strict recommendations from the World Health Organization (WHO) for people who are in close contact with the infected or confirmed COVID-19 cases to wear personal protective equipment (PPE) supported the market growth.
The World Health Organization's recommendations, especially for people in close contact with the infected or confirmed cases, drive market demand. These recommendations suggest the use of personal protective equipment to prevent from further spreading of the disease. There are certain guidelines for the selection of PPE. The guidelines are based on January 2020 guidance which is published by WHO, the European Center for Disease Prevention and Control (ECDC), and the U.S. Centers for Disease Control and Prevention (CDC).
For the selection of the right PPE, the following standards are to be followed; this includes EN 455 + ASTM D6319 + ASTM D3578 for gloves used for medical examinations and surgical procedures, EN ISO 374-5 VIRUS, and ASTM F1671 for hand and body protection against chemicals and microorganisms' risks. EN 14126 for protective clothing against infectious diseases, and EN 149:2001 and AI:2009 for respiratory tract protection for air-borne particulates.
The prevalence of healthcare services is further providing an opportunity for the infection prevention product and services market to thrive in the forecast period and the upcoming years.
Healthcare services categorized as Primary care, Secondary care, Tertiary care, and Quaternary care are also driving the market demand during the forecast period. Primary care involves healthcare professionals who play a role in the local community. This provides care to patients of all ages, different socioeconomic and different geographic regions. Various chronic illnesses can be treated under primary care, including hypertension, diabetes, depression, and anxiety. The professionals involved in primary care would usually be general practitioners or family doctors. Other professionals include nurses or physiotherapists. The key characteristic of primary care is continuity consisting of routine check-ups and preventive care. Depending on the patient's condition, he/she may be advised for secondary or tertiary care.
Secondary care includes the treatment of serious illnesses that require immediate action for a shorter period of time. One can find this kind of facility in the hospital's emergency department, which requires skilled professionals and attendants. Tertiary care is for specialized healthcare services. The personnel are referred via primary and secondary care and require advanced medical investigation and treatment facilities. Examples include cardiac and other complex surgeries. Quaternary care is an extension of tertiary care and makes use of advanced and highly specialized treatments and care. These are not widely accessible but still provide a favorable growth opportunity for the market to proliferate in the forecast period.
The presence of the geriatric population in the world is projected to drive the market demand in the forecast period.
The growing geriatric population has given rise to an increase in healthcare costs to be required for the treatment of non-communicable diseases and chronic diseases related to old age.
Population ageing and growth at advanced stages, above 65 years of age, is giving rise to concerns such as pressure on health systems which needs to adapt in order to meet the growing demands for care, services, and technologies for the prevention and the treatment of the age-associated non-communicable and chronic diseases. Also, as non-communicable diseases and the potential economic & societal costs of these non-communicable diseases rise with age, they can affect economic growth as well. Hence, the growing geriatric population will have a high impact on the growth of the global infection prevention product and services market over the next five years. With the increasing elderly population, there is a significant increase in home healthcare services as well. Thus, this is further surging the market growth in the upcoming years.
Key Developments in the Market
COVID-19 had a positive impact on the global infection prevention product and services market. Owing to the emergence of the coronavirus pandemic, healthcare companies had geared toward the manufacturing of face masks to prevent human-to-human transmission. Also, with the worldwide usage of these protective masks, there had shortage issues as well. Hence, this further pressured the medical companies to speed up their manufacturing to keep pace with the high demand. Consequently, owing to the factors discussed above, the outbreak caused the market size to increase exponentially.
|Market Size Value in 2020||US$123.150 billion|
|Market Size Value in 2027||US$183.530 billion|
|Growth Rate||CAGR of 5.86% from 2020 to 2027|
|Forecast Unit (Value)||USD Billion|
|Segments Covered||Infection Prevention Product and Services, End-User, And Geography|
|Regions Covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies Covered||STERIS, Advanced Sterilization Products, Inc., Ahlstrom-Munksjö, ANSELL LTD., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Mölnlycke Health Care AB, Getinge AB, 3M|
|Customization Scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Q1. What will be the infection prevention product and services market size by 2027?
A1. The global infection prevention product and services market is estimated to reach a market size of US$183.530 billion in 2027.
Q2. What factors are anticipated to drive the infection prevention product and services market growth?
A2. The growing number of acute and chronic diseases is propelling the infection prevention product and services market growth.
Q3. What are the growth prospects for the infection prevention product and services market?
A3. The infection prevention product and services market is estimated to increase at a CAGR of 5.86% during the forecast period.
Q4. Which region holds the maximum market share in the infection prevention product and services market?
A4. On the basis of Geography, North America is estimated to hold a significant share of the infection prevention product and services market with the presence of advanced health facilities.
Q5. What is the size of the global infection prevention product and services market?
A5. Infection Prevention Product And Services Market was valued at US$123.150 billion in 2020.
Advanced Sterilization Products, Inc.
Becton, Dickinson and Company
Mölnlycke Health Care AB
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.